HCMT
ACAD icon

Highland Capital Management (Texas)’s Acadia Pharmaceuticals ACAD Stock Holding History

Highland Capital Management (Texas)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,300
Closed -$679K – 314
2019
Q1 		$679K Buy
+25,300
New +$591K 0.05% 228
2017
Q2 		– Sell
-26,200
Closed -$901K – 290
2017
Q1 		$901K Buy
26,200
+6,200
+31% +$219K 0.05% 198
2016
Q4 		$577K Buy
+20,000
New +$529K 0.03% 215
2014
Q2 		– Sell
-67,833
Closed -$1.65M – 264
2014
Q1 		$1.65M Buy
67,833
+22,833
+51% +$578K 0.07% 136
2013
Q4 		$1.13M Buy
+45,000
New +$1.06M 0.06% 108

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return